Definitive Contract N6264514C4030
Award Date
9/10/14
Potential Completion Date
9/9/18
Potential Value
$17M
Federal Agency
Bureau of Medicine and Surgery
Awardee
Leidos, Inc.
Ultimate Awardee
Leidos Holdings, Inc.
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
San Diego, CA 92106, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract award from the Defense Health Agency (DHA) to Leidos, Inc. for the DOD HIV/AIDS Prevention Program (DHAPP). The contract has a ceiling value of $5,990,577.83 and is a firm fixed-price arrangement. The contract does not have a set-aside designation. The award encompasses a range of services in support of the DHAPP program, including IT hardware and software procurement, cybersecurity solutions, systems engineering, data analytics, program management, and...
This is a $87,336,531.28 cost-plus-fixed-fee delivery order contract awarded by the Bureau of Medicine and Surgery, a Defense agency, to Leidos, Inc. for deployment health research. The contract has a period of performance through February 2030. Leidos has a significant portfolio of federal contracts and subcontracts across multiple agencies, including the Department of Defense, NASA, and civilian organizations, demonstrating broad technical and administrative capabilities. This specific award...
This is a $9,303,241.09 cost-plus-fixed-fee delivery order contract awarded by the Bureau of Medicine and Surgery (part of the Department of Defense) to Leidos, Inc., operating through its Leidos Services Operating Segment Division and doing business as SAIC. The contract, which is not set-aside, is for "Operational Medicine" services with a performance period ending on March 17, 2026. Leidos, a global leader in information technology, engineering, and science solutions, has secured...
This contract was awarded by the Defense Health Agency (DHA) to Leidos, Inc. (Leidos) for delivery order services. The contract has a potential value of $5,617,571.35 and is a cost-plus-fixed-fee type. The contract does not have a set-aside designation. Leidos, through its Leidos Services Operating Segment doing business as Science Applications International Corporation (SAIC), provides a range of IT, engineering, and scientific solutions to federal agencies, including the DHA. This contract...
This is a federal contract award to Leidos, Inc., a global technology and engineering solutions provider, by the Defense Health Agency. The $232,164.80 cost-plus-fixed-fee delivery order contract is for the Fiscal Year 2024 Arthritis Research Program. The contract has a period of performance through June 30, 2025 and was not set aside for a specific business category. Leidos, through its Leidos Services Operating Segment and doing business as SAIC, provides a wide range of technical, scientific,...
The U.S. Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $4,765,471.00 cost-plus-fixed-fee delivery order contract to Leidos Biomedical Research, Inc. to develop and manufacture HIV-1 fusion peptide carrier proteins for use in an HIV vaccine clinical trial. This work is being performed at Leidos Biomedical's facility in Fort Detrick, Maryland. Leidos Biomedical Research, a subsidiary of Leidos...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $26,662,207.00 Cost Plus Fixed Fee delivery order contract to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., to support the development of Anti-HIV Broadly Neutralizing Monoclonal Antibodies for AMP Trials. The contract has a completion date of September 29, 2023 and was awarded on September 30, 2018. The work...
This is a prime contract award to Leidos, Inc., a global technology and engineering solutions provider, for "Diagnostics & Surveillance Research" valued at $19,838,203.29. The contract was awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense. The contract has a period of performance through December 31, 2029 and is a Cost Plus Fixed Fee Delivery Order. There is no set-aside designation for this award. The contract appears to be part of...
This is a federal contract award to Leidos, Inc., a global leader in information technology, engineering, and science solutions. The contract, awarded by the Medical Command agency of the U.S. Department of Defense, is for other direct costs with a ceiling value of $89,518.26. The contract type is a Delivery Order with a Cost Plus Fixed Fee pricing structure, and the ultimate completion date is August 25, 2022. Leidos, operating through its Leidos Services Operating Segment Division and doing...
This is a $8,782,079.00 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Leidos Biomedical Research Inc. The contract is for research, development, and production to support clinical trials for HIV vaccines. Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings, Inc. and operates as a Federally Funded Research and Development Center (FFRDC) contractor for the National Cancer...